Association counts use unique genes with 01-High Priority evidence and unique cells in the authored Specific tier (not the IC-score significance threshold). Reverse counts list meta traits and individual traits separately; these are overlapping levels of evidence, not independent totals. Counts cover the full available catalogue, not the displayed rows or sampled UMAP. Unavailable profiles are excluded from reverse counts; a dash means unavailable or an ambiguous identity, not zero. The browser initially shows 50 rows; choose Rows to change this. Complete rows remain in the HTML, and ordinary page links expose any continuation pages for AI readers and crawlers.
Tissue: Spleen: cell membership
How association tiers are defined — cell–trait and gene–trait
SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.
Cell–trait tiers
- Cell–trait links
- Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
- Required for Specific or Relevant
- The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
- Specific (Tier 1)
- Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
- Relevant (Tier 2)
- Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
- Interpretation and report values
- CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
- Meta traits and individual traits
- Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.
Gene–trait priorities (variant–tCRE–gene evidence)
- Variant–tCRE–gene links
- Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
- Required genetic support
- The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
- Required cellular support
- The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
- High priority
- Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
- Medium priority
- Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
- Same-record evidence and aggregation
- Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
- Limits of interpretation
- A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.
Scope ID: tissue.SPL · tissue
All-cell scope membership reference
Cell-identity scopes include only populations at the same or a finer hierarchy level: parent populations do not list their child identity scopes. Overview, tissue, system, lineage and theme scopes use positive full-cell overlap; overlap does not imply that a population is wholly contained in that scope. Membership uses canonical names and levels from the full atlas, never sampled UMAP cells or legacy scoped aliases. Counts below are full-atlas population counts, not scope-local counts. Scope membership does not recompute or change the all-tissue ranking scores.
Type (L1)
6 canonical populations.
| Browsers | Cell population | Full atlas cell count | Cell-to-scope reference | Meta traits (Specific) | Individual traits (Specific) |
|---|---|---|---|---|---|
| B_cell | 52,476 | All scopes | 356 | 694 | |
| dendritic_cell | 12,586 | All scopes | 496 | 724 | |
| innate_lymphoid_cell_2 | 558 | All scopes | 3 | 8 | |
| monocyte | 108,875 | All scopes | 2,176 | 3,871 | |
| plasma_cell | 21,321 | All scopes | 17 | 24 | |
| T_cell | 286,163 | All scopes | 470 | 959 |
Subtype (L1S)
22 canonical populations.
| Browsers | Cell population | Full atlas cell count | Cell-to-scope reference | Meta traits (Specific) | Individual traits (Specific) |
|---|---|---|---|---|---|
| B.age_associated | 1,265 | All scopes | 207 | 350 | |
| B.germinal_center | 642 | All scopes | 233 | 655 | |
| B.memory | 22,524 | All scopes | 442 | 882 | |
| B.naive | 28,045 | All scopes | 307 | 595 | |
| DC.cDC1 | 809 | All scopes | 55 | 112 | |
| DC.cDC2 | 9,277 | All scopes | 1,189 | 1,793 | |
| ILC2.innate_lymphoid_cell_2 | 558 | All scopes | 2 | 0 | |
| MONO.CD14 | 91,321 | All scopes | 2,294 | 4,139 | |
| MONO.CD16 | 17,554 | All scopes | 1,304 | 1,835 | |
| PC.IgA_muocsal | 18,804 | All scopes | 18 | 31 | |
| PC.IgG_systemic | 2,517 | All scopes | 41 | 60 | |
| T.CD4_cytotoxic | 5,562 | All scopes | 855 | 1,493 | |
| T.CD4_Tcm | 32,382 | All scopes | 494 | 988 | |
| T.CD4_Tem | 11,626 | All scopes | 365 | 697 | |
| T.CD4_Tfh | 4,668 | All scopes | 47 | 45 | |
| T.CD4_transitional | 7,677 | All scopes | 48 | 110 | |
| T.CD4_Treg | 7,092 | All scopes | 244 | 511 | |
| T.CD4_Trm | 14,503 | All scopes | 176 | 363 | |
| T.CD8_Tcm | 7,783 | All scopes | 460 | 926 | |
| T.CD8_Tem | 25,690 | All scopes | 1,083 | 1,857 | |
| T.CD8_transitional | 25,000 | All scopes | 497 | 932 | |
| T.CD8_Trm | 14,664 | All scopes | 211 | 346 |
State (L2)
111 canonical populations.
Membership reference version: 9b81aedc7b46066c709a4506c6c8d91ddea39c9faadf291d1f387158f8a904f7